Join the Facial Wrinkles group to help and get support from people like you.
Facial Wrinkles News (Page 2)
Related terms: Frown Lines, Nasolabial Folds, Smile Lines, Wrinkles, Glabellar Lines, Canthal Lines, Lateral Canthal Lines
FDA Medwatch Alert: Unintentional Injection of Soft Tissue Filler into Blood Vessels in the Face: FDA Safety Communication - Risk of Serious Patient Injury
[Posted 05/28/2015] ISSUE: The FDA has reviewed information that suggests unintentional injection of soft tissue fillers into blood vessels in the face can result in rare, but serious side effects....
FDA Medwatch Alert: Expression Injectable by Enhancement Medical: FDA Safety Communication - Adverse Events Associated with Unapproved Use As a Dermal Filler
ISSUE: The FDA has become aware of adverse events associated with the unapproved use of the Expression product, hyaluronic acid that is packaged in a syringe, as a dermal filler. Events have included...
FDA Approves Botox Cosmetic to Improve the Appearance of Crow’s Feet Lines
WEDNESDAY, September 11, 2013 – The U.S. Food and Drug Administration today approved a new use for Botox Cosmetic (onabotulinumtoxinA) for the temporary improvement in the appearance of moderate to...
FDA Medwatch Alert: Skin Creams, Soaps and Lotions Marketed as Skin Lighteners and Anti-aging Treatments: May Contain the Toxic Metal, Mercury
Issue: FDA notified healthcare professionals and warned consumers not to use skin creams, beauty and antiseptic soaps, or lotions that might contain mercury. The products are marketed as skin...
Merz Aesthetics Announces FDA Approval of Belotero Balance Dermal Filler for the Correction of Moderate-to-Severe Facial Wrinkles and Folds
SAN MATEO, Calif., November 16, 2011 – Merz Aesthetics today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Belotero Balance for the correction of...
Merz Aesthetics Announces FDA Approval Of Xeomin (incobotulinumtoxinA) For The Temporary Improvement In The Appearance Of Moderate To Severe Glabellar Lines In Adult Patients
SAN MATEO, Calif., July 21, 2011 /PRNewswire/ – Merz Aesthetics today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Xeomin (incobotulinumtoxinA) for the...
Fibrocell Science, Inc. Announces FDA Approval for laViv (azficel-T)
EXTON, Pa.--(BUSINESS WIRE)--Jun 22, 2011 - Fibrocell Science, Inc., a cell therapy company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and...
Ask a question
To post your own question to this support group, sign in or create an account.